Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Gains from Sales and Divestitures (2017 - 2025)

Historic Gains from Sales and Divestitures for Sensus Healthcare (SRTS) over the last 9 years, with Q3 2025 value amounting to $10000.0.

  • Sensus Healthcare's Gains from Sales and Divestitures fell 7777.78% to $10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10000.0, marking a year-over-year decrease of 7777.78%. This contributed to the annual value of $72500.0 for FY2024, which is 1026.62% up from last year.
  • Sensus Healthcare's Gains from Sales and Divestitures amounted to $10000.0 in Q3 2025, which was down 7777.78% from $10000.0 recorded in Q2 2025.
  • In the past 5 years, Sensus Healthcare's Gains from Sales and Divestitures ranged from a high of $72500.0 in Q4 2024 and a low of $8750.0 during Q2 2021
  • For the 5-year period, Sensus Healthcare's Gains from Sales and Divestitures averaged around $28444.4, with its median value being $15000.0 (2023).
  • As far as peak fluctuations go, Sensus Healthcare's Gains from Sales and Divestitures plummeted by 8687.51% in 2021, and later skyrocketed by 7142.86% in 2023.
  • Quarter analysis of 5 years shows Sensus Healthcare's Gains from Sales and Divestitures stood at $43750.0 in 2021, then fell by 5.71% to $41250.0 in 2022, then soared by 59.39% to $65750.0 in 2023, then rose by 10.27% to $72500.0 in 2024, then plummeted by 86.21% to $10000.0 in 2025.
  • Its Gains from Sales and Divestitures stands at $10000.0 for Q3 2025, versus $10000.0 for Q2 2025 and $10000.0 for Q1 2025.